ConductScience.org, home

Paper8092829

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.

Berenguer J and 9 others. Antimicrob Agents Chemother, 1994. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Papers, record 8092829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
2.97
iCite
Revised in PubMed
2021-05-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berenguer JJ
2Ali NMN M
3Allende MCM C
4Lee JJ
5Garrett KK
6Battaglia SS
7Piscitelli SCS C
8Rinaldi MGM G
9Pizzo PAP A
10Walsh TJT J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
AspergillosisMajor topic
CyclosporineMajor topic
ItraconazoleMajor topic
Lung Diseases, FungalMajor topic
Animals
Drug Interactions
Female
Kidney
Rabbits

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11310577Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.Am Rev Respir Dis1992https://conductscience.org/library/papers/1310577PubMed
2206642110 year review of invasive aspergillosis detected at necropsy.J Clin Pathol1991https://conductscience.org/library/papers/2066421PubMed
31317280Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.Chemotherapy1992https://conductscience.org/library/papers/1317280PubMed
41605615Effect of cyclodextrin on the pharmacology of antifungal oral azoles.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1605615PubMed
51326309Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment.Eur J Cancer1992https://conductscience.org/library/papers/1326309PubMed
61357148The pharmacokinetics of oral itraconazole in AIDS patients.J Pharm Pharmacol1992https://conductscience.org/library/papers/1357148PubMed
71186493Deep mycotic infection in the hospitalized adult: a study of 123 patients.Medicine (Baltimore)1975https://conductscience.org/library/papers/1186493PubMed
8872495Response optimization of drug dosage: antiarrhythmic studies with tocainide.Clin Pharmacol Ther1977https://conductscience.org/library/papers/872495PubMed
96340275Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation.Transplantation1983https://conductscience.org/library/papers/6340275PubMed
106660859Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6660859PubMed
112992106Itraconazole treatment of murine aspergillosis.Sabouraudia1985https://conductscience.org/library/papers/2992106PubMed
123027843Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.Rev Infect Dis1987https://conductscience.org/library/papers/3027843PubMed
133027853Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.Rev Infect Dis1987https://conductscience.org/library/papers/3027853PubMed
142886752Interaction of cyclosporin and itraconazole.Lancet1987https://conductscience.org/library/papers/2886752PubMed
152889119Itraconazole and cyclosporin nephrotoxicity.Lancet1987https://conductscience.org/library/papers/2889119PubMed
163681380Favorable outcome of invasive aspergillosis in patients with acute leukemia.J Clin Oncol1987https://conductscience.org/library/papers/3681380PubMed
172890938Time course of cyclosporin/itraconazole interaction.Lancet1987https://conductscience.org/library/papers/2890938PubMed
182543220Treatment of invasive aspergillosis with itraconazole.Am J Med1989https://conductscience.org/library/papers/2543220PubMed
192540949Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.Drugs1989https://conductscience.org/library/papers/2540949PubMed
203184859Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits.Lab Anim Sci1988https://conductscience.org/library/papers/3184859PubMed

See all 30 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
41484391Pathologic evaluation of Syzygium aromaticum essential oil against pulmonary aspergillosis in non-neutropenic immunosuppressed rabbits.Sci Rep2026https://conductscience.org/library/papers/41484391PubMed
38175242Aspergillus fumigatus escape mechanisms from its harsh survival environments.Appl Microbiol Biotechnol2024https://conductscience.org/library/papers/38175242PubMed
33007839Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?J Fungi (Basel)2020https://conductscience.org/library/papers/33007839PubMed
32201545Extrapolating Antifungal Animal Data to Humans - Is it reliable?Curr Fungal Infect Rep2020https://conductscience.org/library/papers/32201545PubMed
25587296Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.Can J Infect Dis Med Microbiol2014https://conductscience.org/library/papers/25587296PubMed
24595533Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Clin Pharmacokinet2014https://conductscience.org/library/papers/24595533PubMed
23351398Preparation and evaluation of inhalable itraconazole chitosan based polymeric micelles.Daru2012https://conductscience.org/library/papers/23351398PubMed
22644590New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.Pharm Res2012https://conductscience.org/library/papers/22644590PubMed
19857383What is the role of therapeutic drug monitoring in antifungal therapy?Curr Infect Dis Rep2009https://conductscience.org/library/papers/19857383PubMed
18955533Antifungal therapeutic drug monitoring: established and emerging indications.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/18955533PubMed
17589527Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.Bone Marrow Transplant2007https://conductscience.org/library/papers/17589527PubMed
15015031Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.Eur J Clin Microbiol Infect Dis2004https://conductscience.org/library/papers/15015031PubMed
12202554Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.J Clin Microbiol2002https://conductscience.org/library/papers/12202554PubMed
11585779Antifungal susceptibility testing: practical aspects and current challenges.Clin Microbiol Rev2001https://conductscience.org/library/papers/11585779PubMed
11181372Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11181372PubMed
10639380In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10639380PubMed
9884817Optimisation of itraconazole therapy using target drug concentrations.Clin Pharmacokinet1998https://conductscience.org/library/papers/9884817PubMed
7793887Potential use of a simplified method for determination of itraconazole levels in plasma and esophageal tissue by using high-performance liquid chromatography.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7793887PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8092829

GET https://conductscience.org/api/papers/v1/8092829/references?page=2